These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


77 related items for PubMed ID: 5899133

  • 21. Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins.
    Ware DC, Palmer HR, Pruijn FB, Anderson RF, Brothers PJ, Denny WA, Wilson WR.
    Anticancer Drug Des; 1998 Mar; 13(2):81-103. PubMed ID: 9524553
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. N-Phenyl-N'-(2-chloroethyl)urea analogues of combretastatin A-4: Is the N-phenyl-N'-(2-chloroethyl)urea pharmacophore mimicking the trimethoxy phenyl moiety?
    Fortin S, Moreau E, Lacroix J, Teulade JC, Patenaude A, C-Gaudreault R.
    Bioorg Med Chem Lett; 2007 Apr 01; 17(7):2000-4. PubMed ID: 17291753
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Antineoplastic drugs developed in the USSR].
    Safonova TS, Cernov VA.
    Cesk Farm; 1974 Dec 01; 23(10):416-20. PubMed ID: 4455404
    [No Abstract] [Full Text] [Related]

  • 26. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities.
    Eisenbrand G.
    IARC Sci Publ; 1984 Dec 01; (57):695-708. PubMed ID: 6533062
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Synthesis of the 14C labelled anticancer agent: N,N-bis(beta-chloroethyl)-N',N"-di(carboethoxy-[14C] methyl)-phosphorotriamide].
    Guo JY, Huang L, Tian SH, Zhao QR.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Aug 01; 6(4):295-7. PubMed ID: 6241072
    [No Abstract] [Full Text] [Related]

  • 29. Syntheses and antitumor activity of 4-[N'-[N-(2-chloroethyl)-N-nitrosocarbamoyl]hydrazono]-2,2,6,6- tetramethylpiperidine-1-oxyl.
    Gadjeva V, Raikov Z.
    Pharmazie; 1999 Mar 01; 54(3):231-2. PubMed ID: 10192113
    [No Abstract] [Full Text] [Related]

  • 30. Hungarian anticancer drugs (antineoplastics).
    Kerpel-Fronius S.
    Ther Hung; 1982 Mar 01; 30(3):110-21. PubMed ID: 6095482
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Alkylating agents: mechanisms and modulation.
    Gibson NW.
    Cancer Treat Res; 1989 Mar 01; 42():3-22. PubMed ID: 2577106
    [No Abstract] [Full Text] [Related]

  • 33. Sensitivity of human cell strains having different abilities to repair O6-methylguanine in DNA to inactivation by alkylating agents including chloroethylnitrosoureas.
    Scudiero DA, Meyer SA, Clatterbuck BE, Mattern MR, Ziolkowski CH, Day RS.
    Cancer Res; 1984 Jun 01; 44(6):2467-74. PubMed ID: 6722789
    [Abstract] [Full Text] [Related]

  • 34. Synthesis, structure, and biological activity of ferrocenyl carbohydrate conjugates.
    Ferreira CL, Ewart CB, Barta CA, Little S, Yardley V, Martins C, Polishchuk E, Smith PJ, Moss JR, Merkel M, Adam MJ, Orvig C.
    Inorg Chem; 2006 Oct 02; 45(20):8414-22. PubMed ID: 16999442
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Alkylating activity of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compounds.
    Wheeler GP, Chumley S.
    J Med Chem; 1967 Mar 02; 10(2):259-61. PubMed ID: 6034073
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962.
    De Vita VT, Carbone PP, Owens AH, Gold GL, Krant MJ, Edmonson J.
    Cancer Res; 1965 Dec 02; 25(11):1876-81. PubMed ID: 5858571
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.